Envance Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Envance Technologies's estimated annual revenue is currently $775k per year.
- Envance Technologies's estimated revenue per employee is $193,750
Employee Data
- Envance Technologies has 4 Employees.
- Envance Technologies grew their employee count by 0% last year.
Envance Technologies's People
Name | Title | Email/Phone |
---|---|---|
1 | General Counsel | Reveal Email/Phone |
Envance Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 63 | 7% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | N/A | 15 | 7% | N/A | N/A |
#6 | $0.9M | 11 | -39% | N/A | N/A |
#7 | $1.7M | 9 | 0% | N/A | N/A |
#8 | $0.6M | 3 | 0% | N/A | N/A |
#9 | $4.8M | 31 | -6% | N/A | N/A |
#10 | $6.4M | 36 | 6% | N/A | N/A |
What Is Envance Technologies?
Envance Technologies is a life sciences technology company that develops safe and effective pest control technology and product solutions. Envance was formed in 2012 by AMVAC Chemical Corporation, a wholly-owned subsidiary of American Vanguard Corporation (NYSE: AVD), and TyraTech, Inc. (LON: TYR and TYRU) to develop and commercialize novel insect control technologies, including TyraTech’s Nature’s Technology™ platform, in global consumer, environmental, professional, and agricultural pest control markets. Envance builds strategic commercial partnerships with market-leading companies and provides them with turnkey product and technology innovation to address and transform the global pest control market. www.EnvanceTech.com
keywords:N/AN/A
Total Funding
4
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 4 | -20% | N/A |
#2 | $0.8M | 4 | 0% | N/A |
#3 | $0.3M | 4 | N/A | N/A |
#4 | $0.1M | 5 | 25% | N/A |
#5 | $0.2M | 5 | 67% | N/A |